Marvin Update, News

11 July 2020

By Nicole Ellenrieder

Marvin Direct

– Takes about 4 minutes to read this topic –

Marvin Direct empowers virtual interaction between investigators and their patients as personal contacts are still limited

We are proud to announce the release of Marvin Direct, a GDPR-compliant video chat app to facilitate communication processes in times of COVID-19. As personal meetings between patients and their investigators at research sites and hospitals are still limited, the tool helps clinical study sponsors and CROs overcome these challenges.

Key Features are:

  • End-to-end encryption
  • Full identity protection
  • Central administration portal
  • Independent of the EDC System

The app is compatible with iOS and Android devices and adheres to the privacy and regulatory requirements of the industry. It comes with an administration back end allowing contractual research organizations (CROs) to manage roles and permissions centrally.

Discover the most convenient communication platform for your clinical trials.

CROs and Clinical Study Sponsors may register here for a free account. Once registered, you can get started right away.

Nicole Ellenrieder

Hello, I'm Nicole Ellenrieder

Global Head of Project Management


8 July 2019

HIPAA Compliance Requirements: Keeping Clinical Trial Data Private

Read more


3 June 2019

A Personal Summary of the CDISC European Interchange Conference in Amsterdam

Read more

Clinical Trial Backgrounds, News

8 December 2019

The Increasing Value to Standardizing Data

Read more
Copyright © XClinical. All Rights Reserved.